GREENLAND MINES LTD Warrant, Exercise Price, Decrease
GREENLAND MINES LTD (GRML) reported Warrant, Exercise Price, Decrease of $0.10 per share for the 12-month period ending 2025-12-31, per its 10-K/A filed 2026-08-14.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2026-08-14
- GREENLAND MINES LTD warrant, exercise price, decrease for the quarter ending 2025-03-31 was $0.02.
- GREENLAND MINES LTD warrant, exercise price, decrease for fiscal 2025 was $0.10, a 150.00% increase from fiscal 2024.
- GREENLAND MINES LTD warrant, exercise price, decrease for fiscal 2024 was $0.04.
| Period end | Warrant, Exercise Price, Decrease 3 month | Warrant, Exercise Price, Decrease 6 month | Warrant, Exercise Price, Decrease 9 month | Warrant, Exercise Price, Decrease 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.10 10-K/A · filed 2026-08-14 | |||
| 2025-09-30 | $0.10 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.25 10-Q · filed 2025-08-18 | |||
| 2025-03-31 | $0.02 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $0.04 10-K/A · filed 2026-08-14 | |||
| 2024-09-30 | $0.04 10-Q · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |